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The 3D structure of two unlabeled FK$06 analog-,, (R)- and (S).[18.OHla~omycin, witch bound to [U-'C,"NIFKBP were determined by 
i~top¢-filtcrcd 2D NMR experiments. The structures for the R and $ isomers that bind tishtly to FKBP but lack immunosuppr©~ive activity arc 
compared to each other and to the conformation of the potent immunosupprcs.sant, a~:omycin, wh¢n bound to FKBP, The rcsultt arc interpr¢tegi 
in tares of calcineurin binding to the FKBP/as¢omycin complex, 
FKBP; FK:S06: hnmunosuppr~sant; NMR 
I. INTRODUCTION 
FKS06 is a potent immunosuppressant that binds 
tightly (K., -0,4 riM) to the FKS06 binding protein 
(FKBP-12) [1.21. Recent studies uggest that the im- 
munosuppressive activitiy of FKS06 is due to the inhibi- 
tion of the calcium-dependent phosphatase, calcineurin, 
by the FKf06/FKBP complex [3]. In an attempt o bet- 
ter understand the structural features required for the 
inhibition of ¢alcLneurin by this complex, we have syn. 
thesized several FKS06 analogs and have tested their 
ability to bind to FKBP. and. once bound, their ability 
to inhibit calcineurin [4]. These analogs are derivatives 
of ascomycin [5], also known as FR.900520 [6]. which 
is a potent immunosuppressant closely related to 
FKS06 in structure and activity (Fig, 1). Two analogs 
were discovered..R- and S-[18-OH]aseomycin, that bind 
tightly to FKBP but have little or no immunosupressive 
activity [4,7], In addition, the complexes formed be- 
tween these analogs and FKBP did not inhibit he phos- 
phatase activity of calcineurin [4,7]. In order to probe 
the structural features of these ascomycin analogs that 
might account for their interesting biological properties, 
we have examined their confomaation when bound to 
FKBP. 
Previously. we determined the conformation of 
[U-D~C]ascomycin bound to FKBP via isotope-editing 
techniques [8.9], Using these methods the signals from 
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in8 protein: NOESY, nuclear Ovcrhauscr effect spectra=copy; 
TOCSY, total correlation spectroscopy. 
Cm'respoml~.re a klress: S.W. Fcsik. Pharmaceutital Discovery Divi- 
sion. D-4"/G, APg, Abbott Laboratories, Abbott Park, IL 60064. 
U$A, Fax: (1) ('108) 938.2478, 
the unlabeled protein are suppressed, and only those 
signals from the bound ligand are observed [10-13], 
However, we could not apply these techniques in our 
studies of th= 18-OH analogs due to the difficulties in 
preparing the uniformly ~C-labcled ligands, Therefore, 
we resorted to recently developed isotopc-filterin8 tech- 
niques [14-16] in which the proton NMR ~ignals corre- 
sponding to uniformly ~C-labcled FKBP were effec- 
tively suppressed using a doubly tuned filter [15] to 
allow the selective detection of unlabeled (R)- and (~- 
[18-OH]aseomycin when bound to FKBP. These meth- 
ods offer a powerful alternativ¢ to isotopc.cditin~ tech- 
niques for studying drug/receptor complexes, since they 
do not require isotopically labeled ligands, which in 
most cases cannot be readily obtained. 
2, MATERIALS AND METHODS 
2, l, Sample prcp.mHon 
Synthesis of Ih= [18.OH]a~omycin derivativ=s, via oxidation of 
neomycin by ~leaiurn (IV) oxide, will ~ described indetail elsewhere 
[4]. Rceombin:mt human FKBP.12 was cloned from a Jurkat T cell 
eDNA library and =xpressed in E, co/i using the pKK233-2 vcelor 
cant;lining a trc promoter [17], [U-'C,*~N]FKIIP was prepared by 
growing the FK BP.producing cells on minimal media with [U-'CIac- 
crate as the so1¢ carbon source and ~NH,Ci as the sole nitro@r~ 
,,our¢,¢, and was isolated from these cells using ion-exchange and 
siz¢-exclusion chromatography [1"/]. N M R samples v~r= prepared by 
cxchangin8 the protein into a;H:O solution (pH 6,5) ¢ontainin8 potas- 
sium phosphate (S0 raM). sodium chloride (100 raM}, and dithiothr¢- 
itol-d,o (5 raM). and concentrating the solution to -500 ~1 usin8 a 
centricon.lO microconcentrator, Th:  final FKBP concentration was 
-$ roMe Th¢ [Itl-OH]a~.omycin/FKBP complcx~ wet= prepare d by 
incubatin8 the protein solution o..,=might with an ¢quimolar amount 
o1" each liaand, 
2,3, NMR experiments 
All NMR spectra wee recorded on a Bruker AMXS00(500 MHZ) 
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P'ii~. 1. Struetur~ of" FKS06 and ascomycin. 
spectrometer at 40"C, lsetop¢.fiitcrcd NOESY spectr-, r... = ~ ms, 
were recorded in two dilTerent way==. The first method employed ;= 
conventional, u I. X half.,,lter [llJ] usinll the pulse sequence shown in 
Fill. 2A. The delay. ,d, wz~= set at 3.6 ms. The second method employed 
a doubly.tuned, u, I~lter {15] u~nl# the pulse ~qucnc¢ shown in FiB. 
2B. The delays. ,.t and 4', were sol nt 4.00 end 3.56 ms, respeclivdy, 
=l~J spin.lock pulses ($L) at" 1,00 and I,$0 ms duration were used. An 
i~o|opc.filtcred TOCSY spectrum w~s recorded, ¢,,, = 15 ms, with a 
doubly.tuned filler in both gt and ~, usinlt tl~¢ pulse s¢quence shown 
in Fig. 2C, The delays. 4 and ,d'. w~re r~t at 4,00 and 3,.~ ms. r~sp~. 
lively, and spin.lock pulses ($L) o1" 1.50, I ,00, 0,4~i and 0.?5 ms 
duration were used. E~ch 2D spectrum consisted o1" 256 complex ¢, 
points, with 64 scans per point and with = speetr'4! width in both 
dimensions o1" 10,000 Hx, The final size I'or ¢~ch d~tta set was 
4,09Gxl,024 real points, 
2.3. NOE.#¢riv~l dislm~'¢ r~slrzd;Jls ml~l xtrlz~lltP¢' i'#l<'ltlttlimlx 
For each deri~'ativ~, the proton-proton disl=nce~ mr~d ,,s rcst~ints 
in the structure ¢~lculation wcrc obtained by ¢ountinil contours in the 
80 ms NOESY data set recorded with the doubly-tuned filter. NOEs 
~=r¢ ¢hs~il~cd as eiti~er stronl~ (L,8-2,S A), medium (l,tl-3,4 ~,j or 
weak (1,8.-4.4 A), For distances involvini methyl iiroups, i,0 A was 
added to the upper bound to correct for the p~udoatom {19]. For 
(S).[IE.OH]arcomycin,. total el" ! 11 NOE restraints were used alonl~ 
with .~ lower bound restraints that were determined on tl~e basis of the 
lack o(obsePv.ble NOEs, For the' .~ isomer, l l ' /NOE r~tr..,inzs and 
$ lower bound restraints were used. 
3D strut:lure'= were ¢=lcul-tcd usin~ ~ hybrid dir4ance Ilcom©tryl 
dynamical simulated ann¢=linli protocol [20], Usinii the prol;rm~ 
XPLOPJDG [21,22] and the NOE-dcri~'ed distance r~traints. 200 
initial structures were ilenemtcd itnd sub, iected to 200 steps of Powcll 
re, trained enerly minimixation Io remove ~d van der Weals contacts. 
A) 
'=° !( 
ecru. @4 
=e= I 
+' ' "  ° '  ' ,, ]' ,o I.+.o, 
I I P  , o .o  
| i | ' 
, .  o, , ,  
1~C _ ~,  = ~2 _ .'f, = =% 
II III 
i i I I 
FiB, 2. Pulse sequences used to r~:ord isotope.filtered NOESY and TOCSY spectru. 90* pulr~s are represented by thin bars. 180 ° pulse,~ by thick 
bars and spin.lock pulses by cros,-hatched bars. All pulses are applied .long the X.axis except as indicated ol.herwise, r,. is the NOE mixin8 time, 
(A) NOE~Y sequen¢¢ with conventional, (u~) X halt'filter. @,=4(x)A(-x); @==2(x),2(-x); @s=8(x),8(-x); @4=4(x).8C-x),4(x); ~t= ,-x.  (B) NOESY 
seclu¢nc¢ wilh doubly-tuned {u~) ~ltcr, ~j=4(x),4(-x)~ @:=x,-x; @~=2(x),2C-x); @4=SCx),B(-x); ~s=4(x),8(-x)4(x); 8,=y,-x.-y.x; ,~=x,y.-x,-y, 
{C) TOCSY r~uenc= with doubiy4uncd (u~.u:) ~iltcr, @.=4(x),4( + x); @:=x,-x; ¢~s=2(x).2(-x): ~4=4{x),4(-x}; ~,=y,-x,-y,x; Lg,..=x,y0-x,-y. 
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Fig, 3, l~topc-filtercd spcotnt (S00 Ml-lz) re¢ord=d on the m~or stercoisomcr of llg-OHlascomyoin bound to FKBP, (A) NOESY Sl;nmtrum (rm 
= 80 ms) with conventional, (u,) X half-filter, {B) l'qO -L~Y spectrum (r.. = 80 ms) with doubly-tuned (u,) filter. (C) TOCSY s~trum (r,,= = lfl 
ms) with doubly-tuned (u~,t~,) filter, 
During this minimization, and throuhlhout the entire simulated an- 
ncalinil protocol, the NOE force constant was maintained at 50 
kcal.moi'~.A "=, and electrostatic terms w~re excluded. The minimiza- 
tion step was followesd by ?.5 ps of molecular dynamics (time.step of 
3 Is) at 2,000 K during which the van dcr Waals force constant was 
dcxrea=d from its initial value of 20 kc.ai.mol'l.A ": to a value of 0.003 
kcal.mol".A'; while increasing all other force constants (bond. angle. 
¢tc,), The structuros were then cooled from 2,000 to 100 K in steps of 
S0 K, Each step of the cooling proexss consisted of 1.2S ps ~f re. 
strained molecular dynami¢~ (time-step of 5 fs). The van der Waals 
for¢~ constant was increased at each step by multiplying the prcvlous 
, . |  . "  , 
value by 1.2~I untd a final waluc of 4.0 kcal.mol .A " was obtained, 
The van tier Wauls radius was decreased stcpwi,~ to a final value of 
0,8 tim~ th¢ valuo used in CHARMM for F~,~ [23], In the last stage 
of the refinement, tile structur~ were subjected to 1,000 steps of 
Powdl re, trained energy minimization. 
3. RESULTS AND DISCUSSION 
3.1. Isotope.fihered NMR 
The selective observat ion o f  protons  at tached to "C -  
labeled i igands by suppressing the proton resonances of  
the unlabeled protein is relatively easy to achieve using 
convent ional  isotope-edit ing techniques [10.-13.18], 
However, to suppress the proton signals of  t~C-labeled 
protein and selectively observe the resonances of  the 
unlabeld l igand is more  difficult. The difficulties arise 
from the inabil ity to s imultaneously  tune the fixed de- 
lays. d.  in the convent ional  exper iment  o 1/(2 UH.I 3c) 
(Fig. 2A) for  the diff¢rent t j . ,13  c coupl ings typically 
Table ! 
Structural statistics for (R}- and ($}.[18.OH] ascomycin bound to FKDP 
(R).[I 8OH] ascomycin (S).[I 8OH] ascomycin 
SA, AV., SA, ~.V,. 
rms deviation from distance restraints (A,P 0.014 _+ 0,003 0,012 O,00R _+ o,00i 0.098 
rms deviation from idealized geometry 
bonds (A) 0.00~0 _+ 0,01304 o.oot~ O,O0tl :t: 0,O004 0.0070 
unifies (dog) 2,72 _+ 0,083 2,61 2.55 + 0,O37 2.52 
improp=rs (dog) 0.64 ± 0,05 0,62 0,62 ± 0.03 0,59 
Conformationat Energy 
E~ov. (kcal/mol =) 0,77 ±0,29 0,49 0,20±0,06 0.24 
E,,~ (kc~I/molY 2.78±05"I 2,3S 2.78:1;0.24 I.IN, 
EL.j (kcalhnol)" -3.28:1;0.44 -2.54 -3.1~:±0.78 -3,29 
Atomic rms dilTercnr.e,¢ for all heavy atoms SA~ vs. AV 0,28_+O,I ! SA~ vs, AV 0.37__.0.07 
Sa~ vs. AV,. 0,37:t:0,12 SA, vs, AVm 0.4S±0.19 
AV vs. AV,~ O,~-5 AV vs, AV., 0.30 
• SA~ is the average over the final 80 (R) or I]S (5') structure; AV is the average structure: AV m is the structure obtained after re, trained energy 
minimization of AV, 
h Ergot,. is the cn=rgy contribution from the square.well NOE potential using a force constant of 50 kcal/moI.A:. 
E.~s is the van dcr Waals repulsion cner~ term calculated with the F.,~ potential and a force constant of 4 keal-mol".A <and a hard-sphere 
van der Waals radii 0,8 times the CHARMrvl function. 
" EL,j is the Lennard.Jones van der Waals energy calculat~ using th= CHARMM function, 
3 t l  
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Fig, 4. (A) Supcrposition of the common heavy atoms of the avcnzgc 
NM g structurc of (SI.[I t~-OHlascomycin bound to FKBP to the aver- 
age NMR structure ol' uscomycin (bold) bound to FKBP, The IS 
position is denoted with an aqeri.~k, (B) Superposition of the common 
heavy atoms of the average N M R structure of (R).[ 18.0H]alrcomycin 
bound to FKBP to the average NMR structure of uscomycin bound 
to FKBP, (C) $upcrposition of the common he,iv), attom=~ of the aver. 
nile NMR structure of (R).[lg.OH]ascomycin bound to FKBP to the 
average NMR structure of (~-[IS.OH]aseomycin (bold) bound to 
FKBP. 
found in proteins. Although this is not critical in i~o- 
tope-editing experiments, resulting in only a slight de- 
crease in sensitivity if the delays are not properly set. it 
is very important when attempting to suppress the pro- 
tons attached to s~C-labeled nuclei in isotope-filtering 
experiments [15,16]. 
Fig. 3A depicts an isotope-filtered 2D NOE spectrum 
of (S)-[18-OH]ascomycin bound to [UJ~C, tSN]FKBP 
acquired using the pulse sequence shown in Fig. 2A. 
The artifacts due to the incomplete suppression of the 
proton resonances of s~C-iabeled FKBP, especially near 
the diagonal, make data interpretation very difficult. In 
contrast, using the [sotopc-filtered 2D NOE pulse se- 
quence (Fig. 2B) recently developed in our laboratory 
[15]. that employs two delays which earn be tuned to 
different Un,13c values, superior suppression of ~C- 
attached protons is obtained as illustrated in Fig. 3B, 
The reduction of artifacts allows more NOEs to be un- 
ambiguously interpreted in terms of proton-proton dis- 
tance restraints for generating 3D structures of these 
ligands when bound to FKBP. Similar improvements i  
suppressing the proton signals of [U-L~C, tSN]FKlaP 
were achieved in isotope.filtered 2D TOCSY spectra 
using doub ly tuned filters (e,g. Fig. 3C), aiding in the 
proton resonance assignments of the bound ligands. 
3.2. P¢olott t'Cl$OHtlltCe Ct$,¢igtltttCttL~" 
The proton resonances of (R)- and (,S').[18-OH]as. 
comycin when bound to FKBP were assigned from an 
analysis of isotope-filtered TOCSY spectra acquired 
with a mixing time of 15 ms using the pulse sequence 
shown in Fig. 2C. The scalar-coupled protons could 
readily be traced from the isotope-filtered 2D TOCSY 
spectra such as the one shown in Fig. 3C. The chemical 
shifts were assigned by a comparison with the previ- 
ously assigned chemical shifts of ascomycin when 
bound to FKBP, and were confirmed from isotope- 
filtered 2D NOE data. As in ascomycin [8.9,24]. protons 
at the 3, 4 and 5 position of the piperidine ring appear 
shifted to quite high field >0.3 ppm for both of the 
isomers. This initial observation indicated that their 
overall binding to FKBP must be quite similar to that 
ofascomycin. The overall chemical shifts for both deriv- 
atives are similar to those of ascomycin except for pro. 
tons at or near the 18 position. 
3.3. Determittation fthe atereoehemiatry  the 181)osi. 
tins 
The oxidation of ascomycin by selenium (IV) oxide 
results in two diastereomers which can be separated by 
silica gel chromatography. Initially it was not known 
which stereoisomer was R and which was S. The identi- 
fication of the isomers was accomplished using the NOE 
data. A set of 20 starting structures were generated for 
each isomer using distance geometry, and further re. 
fined with dynamical simulated annealing. During the 
structure calculations, the chirality at the 18 position 
was allowed to float, i.¢. the chirality was allowed to flip 
between R and S to best statisfy the NOE constraints 
[25,26]. For the major isomer, all 20 structures had a 
stereochemistry of S at the 18 position after simulated 
annealing. For the minor isomer, 16 structures were 
obtained with a stereoehemistry of R, while 4 were ob- 
tained with a stereochemistry of 5. We concluded from 
this result hat the major isomer was (S)-[18-OH]as- 
comycin, whii= the minor isomer was (R)-[18-OH]as. 
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Fig 5. Region of the ascomycinlFKBP complex [27J in the vicinity of the ascomycin binding site showing the hydrophobic cleft formed by Tyr-26,
. Phe-46, Arg-42, Lys-44, and part of ascomycin. The 18, pro-R and pro-S positions are labelled Rand S, respectively.
comycin. Therefore, in all ~u.rther structure calculations,
the chirality at the 18 position was fixed.
3.4. Bound conformation
For the final structure calculations, 200 structures
were generated for each isomer which were subse-
quently refined using a dynamical simulated annealing
protocol. For (S)-[18-0H]ascomycin, 85 structures were
chosen that best satisfied the NOE constraints and that
had a trans-7,8 amide bond. The average rms deviation
of all heavy atoms from a calculated average structure
was 0.37 ±0.06 A, and no NOE violations were found
greater than 0.1 A. For (R)-[l8-0H]ascomycin, 80
structures were chosen that best satisfied the NOE con-
straints. The average rms deviation of all heavy atoms
from an average structure was 0.28 ± 0.11 A, and no
NOE violations were found greater than 0.1 A. Thus,
the conformations of both ligands when bound to
FKBP were well defined by the NOE data. Further-
more, as indicated by the structural statistics for both
analogs (Table I), the structures have relatively minor
deviations from idealized geometry.
As shown in Fig. 4A and B, the bound conformations
of both (S)- and (R)-[18-0H]ascomycin are very similar
to the bound conformation of ascomycin. Superposi-
tion of the common heavy atoms of (s)-Il8-0H]as-
comycin and ascomycin gives an rms deviation of 0.49
A, while superposition of the common heavy atoms of
(R)-[18-0H]ascomycin and ascomycin gives an rms de-
viation of 0.36 A. Moreover, as can be seen in Fig. 4C,
the bound conformation of (S)- and (R)-[18-0H]as-
comycin are virtually identical within the experimental
error of the method. The rms deviation for superposi-
tion of their common heavy atoms is 0.49 A. Thus,
substitution of a hydroxyl group for a proton at the 18
positon has essentially no effect on the conformation of
the bound ligand.
4. CONCLUSIONS
Using isotope-filtering techniques the proton chemi-
cal shifts of both the major and minor stereoisomers of
[18-0H]ascomycin bound to FKBP were assigned.
Based on distance geometry/simmulated annealing cal-
culations, the stereochemistry at the 18 position was
defined as S for the major isomer and as R for the minor
isomer. In addition, from isotope-filtered 2D NOE
data, the bound conformations of both isomers were
precisely determined. From a comparison of the 3D
structures of these analogs with that of ascomycin when
bound to FKBP, it can be concluded that the lack of
immunosuppressive activity displayed by these 18-hy-
droxy derivatives is not due to a difference in the con-
formation. The most likely cause of their inactivity as
immunosuppressants is that the protruding 18 hydroxyl
group, at either the R or S position, prevents the FKBPI
ligand complex from interacting with caIcineurin. An
examination of the solution structure of the ascomycinl
FKBP complex [27] re veals a hydrophobic cleft adja-
cent to bound ascomycin, which may form at least part
of the calcineurin binding site. It is formed by the side
chains of Tyr-26, Phe-46, and the aliphatic portion of
Arg-42 and Lys-44, as well as a hydrophobic portion of
ascomycin which includes the methylene group at the 18
position (Fig. 5). If this is, in fact, part of a hydropho-
bic, calcineurin binding site, the addition of a hydroxyl
group at position 18 would disrupt the hydrophobic
surface and might inhibit binding of calcineurin to the
[18-0H]ascomycinlFKBP complex.
In addition to the importance of the structural infor-
mation provided in these studies on FK506 analogs
bound to FKBP, this work represents a good example
of how isotope filtering can be used to determine the
conformation of an unlabeled ligand bound to a BC_
labled protein. In many cases, the synthesis of isotopi-
cally enriched drug molecules will not be possible, sug-
gesting that this approach will be the method of choice
for providing this kind of structural information to aid
in the design of improved pharmaceutical agents.
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